BIOCRYST PHARMACEUTICALS INC·4

May 6, 4:31 PM ET

Frank Steven 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed May 6, 2025

Insider Transaction Report

Form 4
Period: 2025-05-02
Frank Steven
Director
Transactions
  • Award

    Automatic Stock Option Grant

    2025-05-02+4,0794,079 total
    Exercise: $8.93Exp: 2035-05-02Common Stock (4,079 underlying)
  • Award

    Common Stock

    2025-05-02+1,8661,866 total
Footnotes (3)
  • [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest in three equal annual installments beginning on the twelve-month anniversary of the date of grant.
  • [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
  • [F3]The option grant vests 1/36 per month over a 3-year period measured from the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT